[{"quiz_id": "ABMS20260101_gemini-3-pro-preview_p04", "question_id": "ABMS20260101_gemini-3-pro-preview_p04-001", "question": "A 78-year-old female is evaluated for progressive visual dysfunction. She reports difficulty reading and navigating her home, often bumping into doorframes. Her family notes she cannot reach for objects accurately (optic ataxia) and cannot describe the entire scene of a picture (simultanagnosia). Memory and language are relatively preserved. MRI shows predominant atrophy of the parietal and occipital lobes. What is the most likely underlying pathology?", "options": ["Lewy Body Disease", "Prion Disease (CJD)", "Alzheimer's Disease pathology (Amyloid plaques/Tau tangles)", "Frontotemporal Lobar Degeneration (TDP-43)", "Vascular Dementia"], "answer": "C", "answer_index": 2, "explanation": "This patient presents with Posterior Cortical Atrophy (PCA), also known as Benson's syndrome. The clinical hallmark is Balint's syndrome (simultanagnosia, optic ataxia, oculomotor apraxia) and Gerstmann's syndrome. Despite the atypical visual presentation, the underlying pathology in the vast majority (>80%) of PCA cases is Alzheimer's disease (amyloid plaques and neurofibrillary tangles).", "generator_model": "gemini-3-pro-preview", "seed": 130, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Geriatrics", "abms_specialty": "Geriatrics", "abms_source": "target_topic", "source_label_raw": "Geriatrics", "source_quiz_id": "20251223T232137723Z_gemini-3-pro-preview_seed130", "source_question_id": "20251223T232137723Z_gemini-3-pro-preview_seed130-007", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/gemini-3-pro-preview/20251223T232137723Z_gemini-3-pro-preview_seed130", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251223T232137723Z_gemini-3-pro-preview_seed130.jsonl", "pred": "C", "model_outputs": "NOT FOR CLINICAL USE.\n\nThe patient presents with a constellation of symptoms strongly suggestive of Balint's syndrome, characterized by optic ataxia (difficulty reaching for objects under visual guidance) and simultanagnosia (inability to perceive the entire visual scene at once). These symptoms arise from bilateral damage to the parieto-occipital regions of the brain. The reported difficulty reading and navigating home, along with bumping into doorframes, further supports deficits in visual perception, spatial processing, and visuomotor control, all functions primarily mediated by the parietal and occipital lobes. The MRI findings of predominant atrophy in these lobes directly correlate with the clinical presentation.\n\nLet's evaluate the options:\nA. Lewy Body Disease (LBD) typically presents with Parkinsonism, fluctuating cognition, and visual hallucinations, with more diffuse or occipital atrophy rather than specific parieto-occipital predilection leading to Balint's syndrome.\nB. Prion Disease (CJD) typically involves rapidly progressive dementia, myoclonus, and often ataxia, with more widespread cortical involvement. While visual disturbances can occur, the described syndrome is not typical.\nC. Alzheimer's Disease pathology (Amyloid plaques/Tau tangles): A variant of Alzheimer's disease known as Posterior Cortical Atrophy (PCA) is characterized by progressive visual dysfunction, visuospatial deficits, apraxias, and agnosias, with prominent atrophy in the occipital and parietal lobes, often with relative preservation of episodic memory and language in early stages. Balint's syndrome is a common feature of PCA. PCA is most frequently associated with Alzheimer's disease pathology.\nD. Frontotemporal Lobar Degeneration (FTLD) primarily affects the frontal and temporal lobes, leading to behavioral or language disorders. Parietal and occipital lobe atrophy and Balint's syndrome are not typical presentations of FTLD.\nE. Vascular Dementia (VaD) can result from strokes or chronic ischemia affecting various brain regions. Bilateral vascular insults to the occipitoparietal regions can cause Balint's syndrome and subsequent focal atrophy. However, the specific syndrome of Balint's, combined with predominant posterior atrophy and the query about \"underlying pathology\" rather than just \"etiology,\" makes a specific degenerative process like AD pathology (which causes PCA) a very strong contender.\n\nGiven the specific symptoms (optic ataxia, simultanagnosia), the location of atrophy (parietal and occipital lobes), and the relative preservation of memory and language, the clinical picture is highly consistent with Posterior Cortical Atrophy (PCA). PCA is most commonly associated with Alzheimer's disease pathology, specifically the accumulation of amyloid plaques and tau tangles in the posterior brain regions. Therefore, Alzheimer's Disease pathology is the most likely underlying cause.\n\nThe answer is (C)"}, {"quiz_id": "ABMS20260101_gemini-3-pro-preview_p04", "question_id": "ABMS20260101_gemini-3-pro-preview_p04-002", "question": "A 3-day-old neonate presents with intractable seizures refractory to phenobarbital, phenytoin, and levetiracetam. The EEG shows a burst-suppression pattern. Administration of intravenous pyridoxine yields no improvement. Subsequent administration of pyridoxal-5'-phosphate results in immediate cessation of clinical and electrographic seizure activity. Which enzyme is deficient?", "options": ["Antiquitin (ALDH7A1)", "Pyridox(am)ine 5'-phosphate oxidase (PNPO)", "Glutamic acid decarboxylase (GAD)", "GABA transaminase", "Succinic semialdehyde dehydrogenase"], "answer": "B", "answer_index": 1, "explanation": "Pyridoxine-dependent epilepsy (ALDH7A1 deficiency) responds to pyridoxine. However, patients with PNPO deficiency cannot convert pyridoxine to the active form, pyridoxal-5'-phosphate (PLP). They present with similar intractable seizures but require PLP specifically for treatment.", "generator_model": "gemini-3-pro-preview", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Pediatrics", "abms_specialty": "Pediatrics", "abms_source": "target_topic", "source_label_raw": "Pediatrics", "source_quiz_id": "20251223T232137723Z_gemini-3-pro-preview_seed128", "source_question_id": "20251223T232137723Z_gemini-3-pro-preview_seed128-002", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/gemini-3-pro-preview/20251223T232137723Z_gemini-3-pro-preview_seed128", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251223T232137723Z_gemini-3-pro-preview_seed128.jsonl", "pred": "B", "model_outputs": "NOT FOR CLINICAL USE.\nThe question describes a neonate with severe, intractable seizures that do not respond to standard antiepileptic drugs like phenobarbital, phenytoin, and levetiracetam. The EEG pattern (burst-suppression) further indicates severe cerebral dysfunction.\n\nThe response to vitamin B6 (pyridoxine) and its active coenzyme form (pyridoxal-5'-phosphate, PLP) is characteristic of certain types of pyridoxine-dependent epilepsy.\n\nLet's analyze the options in the context of vitamin B6 metabolism and neurotransmitter synthesis:\n\n*   Vitamin B6 Metabolism: Pyridoxine, pyridoxal, and pyridoxamine are dietary forms of vitamin B6. They are phosphorylated topyridoxine-5'-phosphate (PNP), pyridoxal-5'-phosphate (PLP), and pyridoxamine-5'-phosphate (PMP). The critical step for activating these forms into PLP, the biologically active coenzyme, is catalyzed by pyridox(am)ine 5'-phosphate oxidase (PNPO). PLP is essential for the synthesis of GABA from glutamate, a reaction catalyzed by glutamic acid decarboxylase (GAD).\n\n*   Pyridoxine-Dependent Epilepsy (PDE): This condition, often caused by mutations in the ALDH7A1 gene (Antiquitin), leads to the accumulation of α-aminoadipic semialdehyde, which interferes with PLP-dependent enzymes, including GAD. Patients with PDE are typically responsive to high doses of oral pyridoxine.\n\n*   Pyridoxal-5'-Phosphate-Dependent Epilepsy (PLP-DEP): This is a rarer cause of severe infantile epilepsy, characterized by deficiency of PNPO. PNPO deficiency impairs the conversion of PNP and PMP to PLP, leading to a functional PLP deficiency. Seizures are often refractory to standard AEDs. While pyridoxine supplementation may be tried, it may not restore PLP levels effectively due to the enzymatic block. Direct administration of PLP, which bypasses the deficient PNPO enzyme, can lead to rapid and complete seizure cessation.\n\nIn the given case:\n1.  The seizures are intractable and refractory to standard AEDs.\n2.  Administration of intravenous pyridoxine yielded no improvement. This suggests that the problem might not be a simple inability to phosphorylate dietary vitamin B6 or a deficiency of the vitamin itself, but rather a defect in its activation or utilization as a cofactor.\n3.  Subsequent administration of pyridoxal-5'-phosphate (PLP) resulted in immediate cessation of seizures. This indicates that providing the active coenzyme directly resolved the underlying metabolic or neurotransmitter deficit causing the seizures.\n\nThis clinical profile – refractory encephalopathy, lack of response to pyridoxine, and prompt response to PLP – is highly characteristic of pyridoxal-5'-phosphate oxidase (PNPO) deficiency. The deficiency is in the enzyme PNPO, which leads to low levels of active PLP.\n\nLet's evaluate the other options:\nA.  Antiquitin (ALDH7A1) deficiency (PDE) is usually responsive to pyridoxine itself. The prompt failure of pyridoxine makes this less likely.\nC.  Glutamic acid decarboxylase (GAD) is a PLP-dependent enzyme. A deficiency in GAD itself would lead to reduced GABA synthesis, but the problem presented is not directly about GAD itself but rather the supply of its cofactor PLP.\nD.  GABA transaminase (GABA-T) is a PLP-dependent enzyme that catabolizes GABA. Deficiency would lead to increased GABA, not epilepsy.\nE.  Succinic semialdehyde dehydrogenase (SSADH) deficiency is a different metabolic disorder resulting in 4-hydroxybutyric aciduria and has its own characteristic features.\n\nTherefore, the enzyme deficient is Pyridox(am)ine 5'-phosphate oxidase (PNPO).\n\nThe final answer is $\\boxed{B}$."}, {"quiz_id": "ABMS20260101_gemini-3-pro-preview_p04", "question_id": "ABMS20260101_gemini-3-pro-preview_p04-003", "question": "A 45-year-old victim of a residential fire is intubated for airway protection. Due to suspected cyanide toxicity, a specific antidote is administered. Two hours later, the patient requires continuous renal replacement therapy (CRRT) for severe acidosis and acute kidney injury. Shortly after initiation, the CRRT machine repeatedly alarms and stops due to a 'Blood Leak' error, despite visual inspection of the effluent showing no frank blood. What is the mechanism of this technical complication?", "options": ["Hemolysis induced by the antidote", "Rhabdomyolysis myoglobin filtering", "Optical interference by the antidote", "Precipitation of antidote in the filter", "Coagulation of the filter membrane"], "answer": "C", "answer_index": 2, "explanation": "The patient received hydroxocobalamin (cyanokit), which has an intense red color. This chromophore passes into the ultrafiltrate/dialysate and is detected by the optical blood leak detector of the dialysis machine, causing a false-positive alarm that halts therapy. It also interferes with co-oximetry (falsely elevating HbCO) and colorimetric chemistry labs (creatinine, lactate) for days.", "generator_model": "gemini-3-pro-preview", "seed": 125, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Emergency Medicine", "abms_specialty": "Emergency Medicine", "abms_source": "topics_mapped", "source_label_raw": "Emergency Medicine", "source_quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed125", "source_question_id": "20251129T125426901Z_gemini-3-pro-preview_seed125-003", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/gemini-3-pro-preview/20251129T125426901Z_gemini-3-pro-preview_seed125", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026_backup/20251129T125426901Z_gemini-3-pro-preview_seed125.jsonl", "pred": "C", "model_outputs": "NOT FOR CLINICAL USE.\n\nThe question describes a scenario where a CRRT machine is repeatedly alarming with a 'Blood Leak' error despite visual inspection of the effluent showing no frank blood. The patient has received a specific antidote for suspected cyanide toxicity.\n\nLet's analyze the options:\n\nA.  Hemolysis induced by the antidote: If the antidote caused significant hemolysis, free hemoglobin would be released into the bloodstream. This free hemoglobin would be filtered by the CRRT machine and could trigger the 'Blood Leak' alarm. While possible, the prompt states \"no frank blood,\" which might be interpreted as absence of significant hemolysis indicated by visual inspection. Also, common cyanide antidotes like hydroxocobalamin are not typically associated with causing direct hemolysis.\n\nB.  Rhabdomyolysis myoglobin filtering: Rhabdomyolysis could release myoglobin, which could be detected by some sensors. However, there is no information in the vignette to suggest rhabdomyolysis is occurring, making this option less likely. Smoke inhalation from a fire can cause burns or trauma, but rhabdomyolysis is not a guaranteed complication without further context.\n\nC.  Optical interference by the antidote: Cyanide antidotes, particularly hydroxocobalamin (used for cyanide toxicity), are often highly colored (e.g., deep red). CRRT machines use optical sensors (photodetectors) to detect blood in the effluent. These sensors work by measuring light absorbance. A colored antidote circulating in the patient's blood and thus in the CRRT circuit effluent can mimic the optical properties of blood, causing the sensor to generate a false 'Blood Leak' alarm. This is a well-known technical complication.\n\nD.  Precipitation of antidote in the filter: If the antidote precipitated within the filter membrane, it would likely lead to flow or pressure alarms due to obstruction, rather than a 'Blood Leak' alarm. Visual inspection might reveal precipitate, but the description is of a 'Blood Leak' alarm.\n\nE.  Coagulation of the filter membrane: While coagulation of the filter membrane is a common complication in CRRT, it typically leads to decreased blood flow, pressure changes, or visible clots in the effluent. The prompt explicitly states \"despite visual inspection of the effluent showing no frank blood,\" which makes gross coagulation less likely to be the primary cause of *this specific* alarm. If the alarm is triggered by optical means and there's no visible blood, optical interference is a more direct explanation.\n\nConsidering the known properties of cyanide antidotes (especially hydroxocobalamin) and the function of 'Blood Leak' alarms in CRRT, optical interference by a colored antidote is the most plausible mechanism for a false positive alarm when no frank blood is present.\n\nThe final answer is $\\boxed{C}$."}, {"quiz_id": "ABMS20260101_gemini-3-pro-preview_p04", "question_id": "ABMS20260101_gemini-3-pro-preview_p04-004", "question": "A 35-year-old female undergoes a cone biopsy for CIN 3. Pathology reveals invasive squamous cell carcinoma with 2 mm depth of invasion and 5 mm horizontal spread. Lymphovascular space invasion (LVSI) is extensively present. Margins are negative. Imaging shows no lymphadenopathy. She desires future fertility. According to NCCN guidelines, what is the recommended management?", "options": ["Simple trachelectomy", "Radical trachelectomy with pelvic lymph node assessment", "Conization with negative margins is sufficient", "Simple hysterectomy", "Pelvic radiation therapy"], "answer": "B", "answer_index": 1, "explanation": "The patient has Stage IA1 cervical cancer (invasion <= 3mm). However, the presence of Lymphovascular Space Invasion (LVSI) significantly increases the risk of lymph node metastasis and recurrence. Therefore, simple excision (cone) or simple trachelectomy/hysterectomy is insufficient. The recommended management for fertility preservation in IA1 with LVSI is radical trachelectomy with pelvic lymph node assessment (sentinel node or dissection).", "generator_model": "gemini-3-pro-preview", "seed": 124, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Obstetrics and Gynecology", "abms_specialty": "Obstetrics and Gynecology", "abms_source": "topics_mapped", "source_label_raw": "gynecology", "source_quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed124", "source_question_id": "20251129T125426901Z_gemini-3-pro-preview_seed124-010", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/gemini-3-pro-preview/20251129T125426901Z_gemini-3-pro-preview_seed124", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026_backup/20251129T125426901Z_gemini-3-pro-preview_seed124.jsonl", "pred": "B", "model_outputs": "NOT FOR CLINICAL USE.\nThe patient has invasive squamous cell carcinoma of the cervix with a depth of invasion of 2 mm. This would typically be classified as Stage IA2 if lymphovascular space invasion (LVSI) were absent. However, LVSI is extensively present. Extensive LVSI is a significant risk factor for lymph node metastasis, even in early-stage cervical cancer. The patient desires future fertility.\n\nAccording to NCCN guidelines for early-stage cervical cancer (Stages IA2, IB1) in patients desiring fertility, radical trachelectomy is a fertility-sparing surgical option. Crucially, for tumors with risk factors for lymph node metastasis, such as LVSI (especially when extensive), pelvic lymph node assessment (e.g., pelvic lymph node dissection or sentinel lymph node biopsy) is mandatory.\n\nLet's evaluate the options:\nA. Simple trachelectomy: This procedure removes the cervix but is generally less extensive than a radical trachelectomy and may not provide adequate surgical margins for invasive cancer with LVSI. It also doesn't explicitly mention lymph node assessment.\nB. Radical trachelectomy with pelvic lymph node assessment: This option is fertility-sparing, removes the cervix and surrounding tissues with adequate margins, and includes the necessary assessment of pelvic lymph nodes due to the presence of extensive LVSI. This aligns with NCCN recommendations for such cases.\nC. Conization with negative margins is sufficient: While negative margins after conization are ideal for CIN 3, the presence of invasive carcinoma requires more definitive management, especially with high-risk features like extensive LVSI. Conization alone is generally not considered curative for invasive cervical cancer.\nD. Simple hysterectomy: This procedure is not fertility-sparing, which is contrary to the patient's desire.\nE. Pelvic radiation therapy: While a treatment option for cervical cancer, it is generally not fertility-sparing and is not typically the first-line approach for early-stage disease when surgical options, including fertility-sparing ones, are available and oncologically appropriate.\n\nGiven the desire for fertility, the presence of invasive cancer, and the high-risk feature of extensive LVSI, radical trachelectomy combined with pelvic lymph node assessment is the recommended management according to NCCN guidelines.\n\nThe answer is (B)"}, {"quiz_id": "ABMS20260101_gemini-3-pro-preview_p04", "question_id": "ABMS20260101_gemini-3-pro-preview_p04-005", "question": "A patient with a known diagnosis of Erythropoietic Protoporphyria (EPP) is undergoing a prolonged laparotomy. Which of the following intraoperative interventions is most critical to prevent cutaneous injury in this specific patient?", "options": ["Avoidance of nitrous oxide", "Placement of yellow filters over the operating lights", "Strict avoidance of volatile anesthetics", "Administration of high-dose corticosteroids", "Maintenance of normothermia to prevent precipitation"], "answer": "B", "answer_index": 1, "explanation": "Patients with EPP accumulate protoporphyrin IX, which is phototoxic upon exposure to light in the violet/blue spectrum (Soret band, ~400-410 nm). Standard operating lights emit significant energy in this range, causing severe phototoxic skin burns and potential intestinal injury during laparotomy. Yellow filters block this specific wavelength.", "generator_model": "gemini-3-pro-preview", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Anesthesiology", "abms_specialty": "Anesthesiology", "abms_source": "target_topic", "source_label_raw": "Anesthesiology", "source_quiz_id": "20251223T232137723Z_gemini-3-pro-preview_seed128", "source_question_id": "20251223T232137723Z_gemini-3-pro-preview_seed128-004", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/gemini-3-pro-preview/20251223T232137723Z_gemini-3-pro-preview_seed128", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251223T232137723Z_gemini-3-pro-preview_seed128.jsonl", "pred": "B", "model_outputs": "NOT FOR CLINICAL USE.\nRationale: Erythropoietic Protoporphyria (EPP) is characterized by the accumulation of protoporphyrins in the skin, which are readily excited by visible light, particularly in the blue and ultraviolet (UV) spectrum. Exposure to these wavelengths results in immediate cutaneous pain, burning, and swelling. Operating room lights emit light across a spectrum that includes these harmful wavelengths. Prolonged laparotomy means extended exposure. Placing yellow filters over the operating lights blocks the blue and UV light, allowing only longer wavelengths (less damaging) to reach the patient's skin, thereby directly preventing the phototoxic reaction and subsequent cutaneous injury.\n\nA. Nitrous oxide is not a primary trigger for phototoxicity in EPP.\nC. Volatile anesthetics are generally considered safe in EPP, unlike in some other forms of porphyria where specific drugs must be avoided. The issue in EPP is photosensitivity, not increased porphyrin synthesis triggered by anesthetic agents.\nD. High-dose corticosteroids are not the primary or critical intervention for preventing phototoxicity in EPP. Their role is more for managing inflammation if it occurs, not preventing the initial light-induced damage.\nE. While maintaining normothermia is good general perioperative care, it does not directly prevent the phototoxic reaction caused by light exposure, which is the inciting event for cutaneous injury in EPP.\n\nThe most direct and critical intervention to prevent cutaneous injury in EPP during prolonged exposure to surgical lights is to filter out the wavelengths of light that trigger the phototoxic reaction.\n\nThe answer is (B)"}, {"quiz_id": "ABMS20260101_gemini-3-pro-preview_p04", "question_id": "ABMS20260101_gemini-3-pro-preview_p04-006", "question": "A 22-year-old male presents with hypersomnia, hyperphagia, and hypersexuality occurring in distinct episodes lasting two weeks, separated by months of normal behavior. During episodes, he exhibits derealization. Which of the following pharmacologic agents has the strongest evidence for preventing future episodes of this syndrome?", "options": ["Modafinil", "Lithium", "Methylphenidate", "Fluoxetine", "Lorazepam"], "answer": "B", "answer_index": 1, "explanation": "The clinical presentation is classic for Kleine-Levin Syndrome (KLS). While symptomatic treatment involves stimulants, Lithium is the mood stabilizer with the most reported efficacy in reducing the frequency and intensity of the cycling episodes, although evidence is limited to case series and small studies.", "generator_model": "gemini-3-pro-preview", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Psychiatry", "abms_specialty": "Psychiatry", "abms_source": "target_topic", "source_label_raw": "Psychiatry", "source_quiz_id": "20251223T232137723Z_gemini-3-pro-preview_seed128", "source_question_id": "20251223T232137723Z_gemini-3-pro-preview_seed128-007", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/gemini-3-pro-preview/20251223T232137723Z_gemini-3-pro-preview_seed128", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251223T232137723Z_gemini-3-pro-preview_seed128.jsonl", "pred": "B", "model_outputs": "The patient's symptoms (hypersomnia, hyperphagia, hypersexuality, derealization in distinct episodes) are characteristic of Kleine-Levin Syndrome (KLS). The question asks for the pharmacologic agent with the strongest evidence for preventing future episodes.\n\nLet's evaluate the options for KLS prophylaxis:\nA. Modafinil: Primarily used for managing hypersomnia symptoms during an episode or for other sleep disorders. Not considered a primary prophylactic agent for KLS.\nB. Lithium: Has been studied and is often considered a first-line agent for prophylaxis in KLS. Several case series and reviews suggest it can reduce the frequency and severity of episodes.\nC. Methylphenidate: A stimulant, similar to modafinil, more for managing hypersomnia symptoms rather than preventing episodes.\nD. Fluoxetine: An SSRI. While some studies suggest potential benefit for mood symptoms and possibly a reduction in episode frequency, evidence for prophylactic use is generally considered less robust than for lithium.\nE. Lorazepam: A benzodiazepine used for acute management of symptoms like agitation or insomnia during an episode, not for preventing future episodes.\n\nAmong the given options, lithium has the strongest and most consistently reported evidence for preventing future episodes of Kleine-Levin Syndrome.\n\nThe answer is (B)"}, {"quiz_id": "ABMS20260101_gemini-3-pro-preview_p04", "question_id": "ABMS20260101_gemini-3-pro-preview_p04-007", "question": "A 40-year-old female presents with a 3 cm mass in the tail of the pancreas. CT imaging shows a well-circumscribed lesion with peripheral calcification. EUS-FNA is non-diagnostic but shows glycogen-rich cuboidal cells. What is the most likely diagnosis?", "options": ["Serous cystadenoma", "Mucinous cystic neoplasm", "Solid pseudopapillary neoplasm", "Pancreatic neuroendocrine tumor", "Acinar cell carcinoma"], "answer": "A", "answer_index": 0, "explanation": "Serous cystadenomas are benign lesions often found in the pancreatic tail. The classic description includes a 'honeycomb' appearance and a central scar with calcification (though peripheral calcification can occur). The key histologic feature is glycogen-rich cuboidal cells (clear cells) that stain positive for PAS. They have virtually no malignant potential.", "generator_model": "gemini-3-pro-preview", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "General Surgery", "abms_specialty": "General Surgery", "abms_source": "target_topic", "source_label_raw": "General Surgery", "source_quiz_id": "20251223T232137723Z_gemini-3-pro-preview_seed128", "source_question_id": "20251223T232137723Z_gemini-3-pro-preview_seed128-018", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/gemini-3-pro-preview/20251223T232137723Z_gemini-3-pro-preview_seed128", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026/20251223T232137723Z_gemini-3-pro-preview_seed128.jsonl", "pred": "A", "model_outputs": "Rationale:\nThe patient is a 40-year-old female with a 3 cm mass in the tail of the pancreas. CT shows a well-circumscribed lesion with peripheral calcification. EUS-FNA indicates glycogen-rich cuboidal cells.\n\nLet's analyze the options:\nA. Serous cystadenoma (SCA): SCAs are benign cystic neoplasms that are most common in middle-aged women. They are often well-circumscribed and classically show microcystic or macrocystic patterns. Stellate or peripheral calcifications are a hallmark feature of SCAs. Histologically, SCAs are composed of glycogen-rich cuboidal or columnar cells. The combination of peripheral calcification and glycogen-rich cuboidal cells strongly points to SCA.\n\nB. Mucinous cystic neoplasm (MCN): MCNs are also predominantly found in women and can occur in the body or tail of the pancreas. They are typically cystic lesions, but calcifications are less common than in SCAs and are usually mural (within the wall of the cyst) rather than peripheral. The cellular lining is mucin-producing columnar epithelium, not typically described as glycogen-rich cuboidal.\n\nC. Solid pseudopapillary neoplasm (SPN): SPNs are rare tumors that affect young women. While they can occur anywhere in the pancreas and can sometimes show cystic degeneration, calcifications are not a typical feature, and when present, they are often central or flocculent, not peripheral. Histologically, they have peculiar pseudopapillary architecture. The cells themselves can contain glycogen, but the description here fits SCA better with the peripheral calcifications.\n\nD. Pancreatic neuroendocrine tumor (PNET): PNETs are typically solitary, hypervascular lesions on CT, and calcification is uncommon. They are composed of neuroendocrine cells, not glycogen-rich cuboidal cells.\n\nE. Acinar cell carcinoma (ACC): ACC is a malignant tumor composed of acinar cells. Peripheral calcification is not a characteristic feature. The cells are typically serous and basophilic, producing digestive enzymes, and not primarily described by their glycogen content in this context in the way SCA cells are.\n\nTherefore, the presence of peripheral calcification and glycogen-rich cuboidal cells on EUS-FNA is highly diagnostic of a serous cystadenoma.\n\nThe answer is (A)"}, {"quiz_id": "ABMS20260101_gemini-3-pro-preview_p04", "question_id": "ABMS20260101_gemini-3-pro-preview_p04-008", "question": "A 26-year-old female with a history of sensorineural hearing loss and short stature presents with acute onset aphasia and right-sided hemiparesis. MRI shows a T2-hyperintense lesion in the left temporal lobe that does not conform to a vascular territory. Serum lactate is elevated. Which of the following agents is indicated for the acute management of this condition?", "options": ["Intravenous Tissue Plasminogen Activator (tPA)", "Intravenous Arginine", "Intravenous Heparin", "High-dose Aspirin", "Plasma Exchange"], "answer": "B", "answer_index": 1, "explanation": "The clinical picture (stroke-like episode not respecting vascular territories, hearing loss, elevated lactate) is classic for MELAS (Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like episodes). The stroke-like episodes are due to metabolic failure and microvascular angiopathy (nitric oxide deficiency), not thrombotic occlusion. Intravenous Arginine is the recommended acute treatment to improve nitric oxide availability and cerebral blood flow. tPA is not indicated and could be harmful.", "generator_model": "gemini-3-pro-preview", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Neurology", "abms_specialty": "Neurology", "abms_source": "topics_mapped", "source_label_raw": "Neurology", "source_quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed123", "source_question_id": "20251129T125426901Z_gemini-3-pro-preview_seed123-007", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/gemini-3-pro-preview/20251129T125426901Z_gemini-3-pro-preview_seed123", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026_backup/20251129T125426901Z_gemini-3-pro-preview_seed123.jsonl", "pred": "E", "model_outputs": "The patient presents with acute neurological deficits (aphasia, right hemiparesis) suggestive of a stroke. However, several features point away from a typical ischemic stroke due to arterial occlusion:\n1.  Young age: While strokes can occur in young adults, the etiology is often different from older adults.\n2.  Atypical MRI lesion: The lesion not conforming to a vascular territory is a key finding. Typical ischemic strokes follow the distribution of affected arteries. Lesions that do not follow vascular territories can be seen in conditions like tumors, inflammatory processes, metabolic disorders, or certain types of stroke not due to occlusion (e.g., small vessel disease, transient hypoperfusion in specific circuits, or metabolic insults).\n3.  History: Sensorineural hearing loss and short stature, in conjunction with neurological symptoms, raise suspicion for a syndromic diagnosis.\n4.  Elevated serum lactate: This is a strong indicator of impaired mitochondrial function or anaerobic metabolism.\n\nThe combination of stroke-like episodes, sensorineural hearing loss, short stature, and elevated serum lactate in a young individual is highly suggestive of MELAS (Mitochondrial Encephalopathy, Lactic Acidosis, and Stroke-like episodes). MELAS is a mitochondrial disorder affecting energy production, leading to brain lesions that typically occur in the posterior circulation but can vary, and do not respect vascular territories. The elevated lactate reflects the underlying metabolic defect.\n\nNow let's consider the management options in the context of suspected MELAS:\nA.  Intravenous Tissue Plasminogen Activator (tPA): tPA is a thrombolytic agent indicated for acute ischemic stroke caused by arterial occlusion. Since MELAS stroke-like episodes are not typically due to arterial occlusion, tPA is generally not indicated and could be harmful.\nB.  Intravenous Arginine: L-arginine is often used as a supportive treatment in MELAS. It may improve endothelial function by increasing nitric oxide production and has been shown to potentially reduce the frequency and severity of stroke-like episodes. However, it's typically considered a therapeutic adjunct rather than the primary acute intervention modality for managing the acute episode itself in the same way plasma exchange is.\nC.  Intravenous Heparin: Heparin is an anticoagulant used for specific thrombotic or embolic conditions. It is not indicated for the underlying pathophysiology of MELAS.\nD.  High-dose Aspirin: Aspirin is an antiplatelet agent. While useful in secondary prevention or certain specific acute stroke types (e.g., venous sinus thrombosis), it is not the primary treatment for MELAS stroke-like episodes.\nE.  Plasma Exchange: Plasma exchange (plasmapheresis) is a recognized adjunctive therapy in the management of acute stroke-like episodes in MELAS. It is believed to help by removing potentially toxic metabolites or improving microcirculation. Although the evidence for its widespread use and definitive efficacy is debated, it remains an indicated treatment option when MELAS is suspected and supported by the clinical presentation. Given the strong suspicion for MELAS based on the provided vignette, plasma exchange is the most appropriate acute management agent among the choices.\n\nThe final answer is $\\boxed{E}$."}, {"quiz_id": "ABMS20260101_gemini-3-pro-preview_p04", "question_id": "ABMS20260101_gemini-3-pro-preview_p04-009", "question": "A 14-year-old boy with a history of exercise-induced syncope is diagnosed with Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT) confirmed by an RyR2 mutation. He is compliant with high-dose Nadolol. A repeat exercise stress test shows a reduction in arrhythmia burden, but he still develops runs of bidirectional ventricular tachycardia at peak exertion. Which of the following is the best next step in management?", "options": ["Switch Nadolol to Metoprolol Succinate", "Add Flecainide", "Perform Radiofrequency Ablation of the ventricular focus", "Implant a dual-chamber pacemaker", "Add Verapamil"], "answer": "B", "answer_index": 1, "explanation": "In patients with CPVT who have breakthrough arrhythmias despite optimal beta-blocker therapy (preferably Nadolol or Propranolol), the addition of Flecainide is the guideline-recommended next step. Flecainide has a direct blocking effect on the cardiac ryanodine receptor (RyR2), addressing the underlying mechanism. Radiofrequency ablation is generally ineffective due to the polymorphic/multifocal nature of the arrhythmia.", "generator_model": "gemini-3-pro-preview", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Cardiovascular", "abms_specialty": "Cardiovascular", "abms_source": "topics_mapped", "source_label_raw": "cardiology", "source_quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed123", "source_question_id": "20251129T125426901Z_gemini-3-pro-preview_seed123-006", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/gemini-3-pro-preview/20251129T125426901Z_gemini-3-pro-preview_seed123", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026_backup/20251129T125426901Z_gemini-3-pro-preview_seed123.jsonl", "pred": "B", "model_outputs": "NOT FOR CLINICAL USE.\nThe patient has Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT) due to an RyR2 mutation and is symptomatic despite high-dose Nadolol.\nNadolol is the first-line treatment for CPVT. When high doses are insufficient and the patient remains symptomatic or at risk, adjunctive therapy is considered.\nFlecainide, a Class Ic antiarrhythmic, has shown efficacy in CPVT, particularly in RyR2-related forms. It works by blocking the L-type calcium channels in ventricular myocytes, which helps to reduce calcium overload in the sarcoplasmic reticulum, thereby suppressing the arrhythmogenic triggered activity precipitated by catecholamines or adrenergic stimulation.\nSwitching to a different beta-blocker (Metoprolol Succinate) may not be as effective as Maximizing Nadolol or adding a complementary agent, as Nadolol is often preferred for its non-selective and long-acting properties in CPVT.\nRadiofrequency ablation is generally not effective for CPVT because the arrhythmogenic substrate is diffuse rather than localized to a single focus.\nImplanting a pacemaker is not indicated for the treatment of CPVT.\nVerapamil, a calcium channel blocker, can be detrimental in CPVT caused by RyR2 mutations as it can paradoxically increase intracellular calcium transiently and worsen the arrhythmia.\n\nTherefore, adding Flecainide to the high-dose Nadolol regimen is the best next step in management for this patient.\n\nThe final answer is $\\boxed{B}$."}, {"quiz_id": "ABMS20260101_gemini-3-pro-preview_p04", "question_id": "ABMS20260101_gemini-3-pro-preview_p04-010", "question": "A 32-year-old female presents with amenorrhea and galactorrhea. MRI reveals a 4.5 cm pituitary macroadenoma with invasion into the cavernous sinus. Visual fields are intact. Serum prolactin is reported as 145 ng/mL (Reference: <25 ng/mL). Which of the following is the most appropriate next step in management?", "options": ["Option A: Referral for transsphenoidal resection", "Option B: Stereotactic radiosurgery", "Option C: Measurement of prolactin in diluted serum", "Option D: Octreotide scintigraphy", "Option E: Bilateral inferior petrosal sinus sampling"], "answer": "C", "answer_index": 2, "explanation": "A 4.5 cm prolactinoma should typically produce prolactin levels >1,000-10,000 ng/mL. A mildly elevated level in the setting of a giant adenoma suggests the 'Hook Effect,' where excessive antigen saturates the assay antibodies, preventing sandwich formation and leading to a falsely low result. Diluting the sample (1:100) reveals the true elevated value. Confirming a prolactinoma is crucial because dopamine agonists (cabergoline) are the first-line treatment, not surgery.", "generator_model": "gemini-3-pro-preview", "seed": 127, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Endocrine", "abms_specialty": "Endocrine", "abms_source": "topics_mapped", "source_label_raw": "endocrinology", "source_quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed127", "source_question_id": "20251129T125426901Z_gemini-3-pro-preview_seed127-005", "source_runs_root": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs", "source_run_dir": "/home/dbernardo/Documents/pyres/MedEvalArena/eval_results/quizbench/quizzes_Jan2026/runs/gemini-3-pro-preview/20251129T125426901Z_gemini-3-pro-preview_seed127", "source_quiz_path": "/home/dbernardo/Documents/pyres/MedEvalArena/quizzes/quizzes_Jan2026_backup/20251129T125426901Z_gemini-3-pro-preview_seed127.jsonl", "pred": "C", "model_outputs": "The patient presents with symptoms of hyperprolactinemia (amenorrhea, galactorrhea) and a pituitary macroadenoma with an elevated serum prolactin level of 145 ng/mL. The reference range is <25 ng/mL.\n\nWe need to determine the most appropriate next step in management.\n\n1.  Prolactinomas: While prolactinomas are the most common cause of clinically significant hyperprolactinemia, macroadenomas (>10 mm) can also cause mild to moderate prolactin elevation due to the \"stalk effect\" (compression of the pituitary stalk, impairing dopamine inhibition of prolactin release from normal pituitary tissue), even if they are not prolactin-secreting themselves.\n2.  Medical Management: The first-line treatment for symptomatic prolactinomas, regardless of size, is typically medical therapy with dopamine agonists (e.g., cabergoline or bromocriptine). These medications are highly effective in reducing prolactin levels, shrinking the tumor, and restoring reproductive function.\n3.  Macroadenoma Consideration: A 4.5 cm macroadenoma can also cause symptoms by mass effect. However, in this case, the primary symptoms (amenorrhea, galactorrhea) and the elevated prolactin level strongly suggest a hormonal issue is predominant. Visual fields are intact, suggesting no significant chiasmal compression.\n4.  Macroprolactin: Very high prolactin levels (>500-1000 ng/mL) can sometimes be falsely low due to a \"hook effect\" artifact, which can be investigated by diluting the serum. However, a prolactin level of 145 ng/mL is not typically high enough to cause a hook effect artifact.\n    Another consideration is \"macroprolactin,\" which is biologically inactive aggregate of prolactin. Macroprolactin can lead to elevated measured prolactin levels. Many guidelines suggest investigating for macroprolactin in cases of hyperprolactinemia, especially when the prolactin level is above 100-150 ng/mL, or when the clinical presentation is not entirely typical. If the measured prolactin elevation is primarily due to macroprolactin, the biologically active prolactin level might be normal or only mildly elevated, which could alter the management strategy. Testing for macroprolactin can be done by methods such as polyethylene glycol (PEG) precipitation or by measuring prolactin in diluted serum, as suggested in Option C.\n\nLet's evaluate the options:\n\nA.  Referral for transsphenoidal resection: Surgery is typically reserved for macroadenomas that cause significant mass effect symptoms refractory to medical treatment, or in cases where medical therapy is contraindicated or ineffective, or if the adenoma is not responsive to dopamine agonists. Since medical therapy is usually the first-line treatment for hyperprolactinemia, and the question asks for the *next* step, surgery is usually not the immediate next step unless there are specific indications not fully detailed here (e.g., rapid tumor growth, severe mass effect not resolving with medication).\n\nB.  Stereotactic radiosurgery: This is not a first-line treatment for prolactinomas. It is usually considered for residual tumor after surgery or for adenomas unresponsive to medical or surgical management.\n\nC.  Measurement of prolactin in diluted serum: Given the prolactin level of 145 ng/mL, which is a significant elevation but not extremely high, investigating the possibility of macroprolactin is a prudent diagnostic step. This test helps determine if the measured prolactin accurately reflects biologically active prolactin. If significant macroprolactin is present, it could explain the symptoms or indicate that the true biologically active prolactin level is lower than measured, potentially influencing the decision to initiate dopamine agonist therapy or the urgency of treating the macroadenoma based on mass effect concerns. This step helps refine the diagnosis and guides subsequent management.\n\nD.  Octreotide scintigraphy: Octreotide scintigraphy is used to image somatostatin receptor-positive tumors, which are not characteristic of prolactinomas.\n\nE.  Bilateral inferior petrosal sinus sampling (BIPSS): BIPSS is primarily used to lateralize the source of ACTH secretion in Cushing's disease or to differentiate pituitary from ectopic hormone production in rare cases. It is not indicated for the workup of hyperprolactinemia.\n\nConsidering the options, clarifying the nature of the prolactin elevation is crucial. If the elevation is due to macroprolactin, the management strategy may differ from treating a pure prolactinoma. Therefore, measuring prolactin in diluted serum (or equivalent test for macroprolactin) is the most appropriate next step to ensure accurate diagnosis and tailored management.\n\nThe final answer is $\\boxed{C}$."}]